Article
Mutations in HCV non-structural genes do not contribute to resistance to nitazoxanide in replicon-containing cells.
Antiviral research - 1 Sept 2011
Yon Changsuek, Viswanathan Prasanth, Rossignol Jean-François, Korba Brent
Abstract excerpt
Nitazoxanide (NTZ) exhibits potent antiviral activity against hepatitis C virus (HCV) in cell culture. Previously, HCV replicon-containing cell lines resistant to NTZ were selected, but transfer the HCV NTZ-resistance phenotype was not observed following transfection of whole cell RNA. To further explore the nature of the resistance of HCV to NTZ, full length HCV replicon sequences were obtained from two...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
